FDA approves quick malaria test

Jun 27, 2007

The U.S. Food and Drug Administration has approved the Binax NOW Malaria Test, the first rapid test authorized for laboratory use in the United States.

Standard laboratory tests for malaria require identifying parasites in a blood sample under a microscope -- a difficult task requiring training and experience.

The FDA said the new test is significantly faster and easier to use, producing results in 15 minutes after a few drops of whole blood are placed on a dipstick.

The test can also differentiate the most dangerous malaria parasite, Plasmodium falciparum, from less virulent malaria parasites. Results, however, still need to be confirmed using standard microscopic evaluation, the FDA noted.

Malaria was eliminated in the United States during the 1950s but citizens can become infected while traveling in other countries. There were 1,528 new U.S. cases of malaria reported during 2005, including seven deaths. The FDA said nearly all deaths can be prevented if the infection is diagnosed and treated early.

FDA scientists found the Binax NOW test was 95 percent accurate compared with standard microscopic diagnosis in a multi-center study.

The test is manufactured by Binax Inc., a subsidiary of Inverness Medical Innovations Inc.

Copyright 2007 by United Press International

Explore further: First device approved for dialysis-related amyloidosis

add to favorites email to friend print save as pdf

Related Stories

Non-human sugar in biotech drugs causes inflammation

Jul 25, 2010

Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response ...

Recommended for you

FDA launches first app to identify drug shortages

10 hours ago

(HealthDay)—A mobile phone application (app) has been released to identify current drug shortages, resolved shortages, or discontinuations of drug products, according to a press release published by the ...

FDA approves first lower-cost biotech drug (Update)

13 hours ago

Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.

A look at the growing use of synthetic drugs

14 hours ago

In recent years, hundreds of new synthetic recreational drugs have emerged – drugs that neither the general public nor the scientific community know very much about. Many of these new synthetic drugs – ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.